Altimmune Inc Acceptance of IND for Covid-19 Therapeutic Testing - Call Transcript
Greetings. Welcome to Altimmune, Inc. T-COVID Conference Call. (Operator Instructions) As a reminder, this conference call is being recorded.
It is now my pleasure to introduce your host, Ms. Monique Kosse with LifeSci Advisors. Thank you. You may begin.
Thank you, operator, and thank you, everyone, for participating in today's T-COVID Conference Call. Leading the call today will be Vipin Garg, Chief Executive Officer of Altimmune. Also participating on the call today is Scot Roberts, Chief Scientific Officer; Scott Harris, Chief Medical Officer; and Will Brown, Chief Financial Officer.
After their prepared remarks, we will open up the call for a question-and-answer session. A press release announcing the launch of the T-COVID program was issued this morning and can be found on the Investors page of the company's website.
Before we begin, I would like to remind everyone that remarks about future expectations, plans and prospects constitute forward-looking statements for the purposes of the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |